HNF4-α antagonist and use thereof
US-9795586-B2 · Oct 24, 2017 · US
This page is not indexed by search engines while we improve data quality.
Nat Cancer Ct patents in 2017
Nat Cancer Ct was listed as an assignee on 16 patent publications in 2017.
| Metric | Value |
|---|---|
| Company | Nat Cancer Ct |
| Year | 2017 |
| Patents | 16 |
Patents
Representative publications for Nat Cancer Ct in 2017.
Method of predicting reaction to sorafenib treatment using gene polymorphism
US-2017211147-A1 · Jul 27, 2017 · US
Peptides derived from NCAPG2 and their use
US-9708378-B2 · Jul 18, 2017 · US
HNF4-alpha ANTAGONIST AND USE THEREOF
US-2017189371-A1 · Jul 6, 2017 · US
Mutant CTLA4 gene transfected T cell and composition including same for anticancer immunotherapy
US-9688740-B2 · Jun 27, 2017 · US
Top CPC classifications
Most common classification codes for Nat Cancer Ct in 2017.
| CPC | Patents |
|---|---|
| A61P35/00 | 6 |
| G01N33/5011 | 4 |
| A61K38/00 | 3 |
| A61K38/1709 | 3 |
| C07K14/47 | 3 |
Related pages
Navigate to parent entity pages.